Compare Definium Therapeutics Inc. Common Shares (DFTX) vs IQIYI Inc - ADR (IQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs IQIYI Inc - ADR — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.68 (market cap $4.59B), while IQIYI Inc - ADR trades at $1.03 (market cap $974.67M). The key difference: Definium Therapeutics Inc. Common Shares is far larger — about 4.7× IQIYI Inc - ADR's market cap, and Definium Therapeutics Inc. Common Shares is trading nearer its 52-week high, IQIYI Inc - ADR nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and IQIYI Inc - ADR for 55 Days on average.
| DFTX | IQ | |
|---|---|---|
Market Cap | $4.59B | $974.67M |
Volume | 2,103,937 | 4,964,108 |
Sector | Health | Media |
52-Week High | $48.45 | $2.35 |
52-Week Low | $10.68 | $0.86 |
Typical Hold Time | 0 Days | 55 Days |
Enterprise Value | $3.55B | $2.47B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
iQIYI (IQ) trades at $1.015, up 0.5% with neutral technical signals. The company reported Q2 2026 revenue of $6.3 billion (up 1% sequentially) but posted a net loss of -$206 million in 2025. Valuation metrics show mixed signals with low P/S (0.25) and P/B (0.52) ratios but elevated P/E (144.05) due to negative earnings. Recent news highlights AI-driven content expansion with over 350 new titles announced for 2026-2027.
Investment outlook remains cautious despite analyst consensus leaning bullish (50% buy ratings). The streaming business faces revenue pressure with 2026 projections showing -3.22% net margin, though AI content initiatives could improve cost structure. Key risks include Chinese regulatory environment and streaming competition. Institutional sentiment appears divided given mixed technical indicators and fundamental challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About IQIYI Inc - ADR
iQIYI Inc is an online entertainment service provider in China. It is primarily engaged in providing a variety of services encompassing internet video, live broadcasting, online games, online literature, animations, e-commerce, and social media platform. The company produces original video content and distributes appealing professionally produced content, partner-generated content, and user-generated content. It also offers a diverse collection of internet video content that appeals to users from broad demographics. The company's revenue is generated from membership services and online advertising services. The company earns most of its revenue from China.
Read more on IQ →
